WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Gap Down – Here’s What Happened

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWYGet Free Report)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $12.84, but opened at $12.33. WuXi Biologics (Cayman) shares last traded at $12.55, with a volume of 2,400 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, WuXi Biologics (Cayman) has a consensus rating of “Hold”.

View Our Latest Report on WXXWY

WuXi Biologics (Cayman) Trading Up 2.9%

The firm’s 50-day moving average price is $10.53 and its 200-day moving average price is $9.42.

About WuXi Biologics (Cayman)

(Get Free Report)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.

Further Reading

Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.